2017
DOI: 10.1371/journal.pone.0169702
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells

Abstract: ObjectiveRheumatoid arthritis (RA) is an autoimmune inflammatory disease affecting joints. Elevated plasma levels of microRNA-223-3p (miR-223-3p) in patients with RA are implicated in the pathogenesis of the disease. This study aimed to analyze the functional role of miR-223-3p in the pathogenesis of RA by overexpressing miR-223-3p in synovial cell lines.MethodsArthritis was induced in the RA model of SKG mice by injection of ß-glucan. The histopathologic features of joints were examined using hematoxylin and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(14 citation statements)
references
References 49 publications
1
12
0
Order By: Relevance
“…Of course, in addition to affecting the TLR4/TLR2/NF-κB/STAT3 signaling pathway and directly affecting the levels of inflammatory factors, miR-223-3p may also impact the expression of inflammatory factors via other pathways, such as miR-223, which is highly expressed in the bone marrow cells and reportedly inhibits IL-6 by targeting the inflammatory body sensor NLRP3 [31]. Further, miR-223-3p may up-regulate the expression of IL-6 in synoviocytes by down-regulating the expression of IL-17 receptor D [32]. In addition, miR-223 affects IL-6 secretion in mast cells via the insulin-like growth factor 1 receptor/PI3K signaling pathway [22].…”
Section: Discussionmentioning
confidence: 99%
“…Of course, in addition to affecting the TLR4/TLR2/NF-κB/STAT3 signaling pathway and directly affecting the levels of inflammatory factors, miR-223-3p may also impact the expression of inflammatory factors via other pathways, such as miR-223, which is highly expressed in the bone marrow cells and reportedly inhibits IL-6 by targeting the inflammatory body sensor NLRP3 [31]. Further, miR-223-3p may up-regulate the expression of IL-6 in synoviocytes by down-regulating the expression of IL-17 receptor D [32]. In addition, miR-223 affects IL-6 secretion in mast cells via the insulin-like growth factor 1 receptor/PI3K signaling pathway [22].…”
Section: Discussionmentioning
confidence: 99%
“…IL-17RD was found to negatively regulate Toll-like receptor (TLR)-induced immune responses by targeting TIR adaptor protein, which sequentially inhibited the downstream signaling of TLR [ 44 ]. Furthermore, the heteromer of IL-17RD and TNF receptor 2 (TNFR2) has been reported to play a role in the activation of NF-κB signaling [ 45 ], and a relationship between IL-17RD and miR-223-3p has been identified in previous studies [ 46 ]. In the current study, gga-miR122-5p, gga-miR-193b-3p, gga-miR-34b-5p, and miR-223-3p were negatively correlated with IL-17RD during NDV infection, indicating that IL-17RD may play an important role in NDV infection.…”
Section: Discussionmentioning
confidence: 99%
“…This result was also confirmed by Wu's 2019 study. In addition, miR-223 could also inhibit the expression of inflammatory factors such as IL-6 by targeting NLRP3 [53], upregulate the expression of IL-6 in synoviocytes by downregulating the expression of IL-17 receptor D [54], and, through the IGF-1/PI3K signaling pathway, affect the secretion of IL-6 in mast cells [55]. hypothesize that aerobic exercise could increase the expression of miR-223 in the hippocampus of CUMS-depressed mice and slow down the hippocampal inflammatory response in depressed mice, which is mediated by the activation of the TLR4/MyD88-NF-κB pathway.…”
Section: Discussionmentioning
confidence: 99%